Scholars@Duke publication: Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high-risk T-cell lymphoblastic lymphoma?

construction release_alert

Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.

cancel

Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high-risk T-cell lymphoblastic lymphoma?

Publication , Journal Article

Young, KH

Published in: Cancer Commun (Lond)

March 2021

Published version (DOI) Link to item

Duke Scholars

Author Ken H Young Pathology

Altmetric Attention Stats

Dimensions Citation Stats

Published In

Cancer Commun (Lond)

DOI

10.1002/cac2.12148

EISSN

2523-3548

Publication Date

March 2021

Volume

41

Issue

3

Start / End Page

273 / 274

Location

United States

Related Subject Headings

T-Lymphocytes
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Humans
Hematopoietic Stem Cell Transplantation
3211 Oncology and carcinogenesis

Citation

APA

Chicago

ICMJE

MLA

NLM

Young, K. H. (2021). Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high-risk T-cell lymphoblastic lymphoma? Cancer Commun (Lond), 41(3), 273–274. https://doi.org/10.1002/cac2.12148

Young, Ken H. “Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high-risk T-cell lymphoblastic lymphoma?” Cancer Commun (Lond) 41, no. 3 (March 2021): 273–74. https://doi.org/10.1002/cac2.12148.

Young KH. Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high-risk T-cell lymphoblastic lymphoma? Cancer Commun (Lond). 2021 Mar;41(3):273–4.

Young, Ken H. “Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high-risk T-cell lymphoblastic lymphoma?” Cancer Commun (Lond), vol. 41, no. 3, Mar. 2021, pp. 273–74. Pubmed, doi:10.1002/cac2.12148.

Young KH. Intensive chemotherapy and sequential hematopoietic stem cell transplantation: Is it necessary for high-risk T-cell lymphoblastic lymphoma? Cancer Commun (Lond). 2021 Mar;41(3):273–274.

Published In

Cancer Commun (Lond)

DOI

10.1002/cac2.12148

EISSN

2523-3548

Publication Date

March 2021

Volume

41

Issue

3

Start / End Page

273 / 274

Location

United States

Related Subject Headings

T-Lymphocytes
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Humans
Hematopoietic Stem Cell Transplantation
3211 Oncology and carcinogenesis